I-Mab Biopharma (IMAB) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts IMAB Hot Sheet
Join SI Premium – FREE
I-Mab Biopharma (NASDAQ: IMAB) reported Q2 EPS of ($0.09), $0.22 better than the analyst estimate of ($0.31).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Paramount Skydance clears global regulators for WBD deal, faces state AG suit
- Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
